Gemtesa patent expiration date?

When does the Gemtesa (vibegron) patent expire?

Gemtesa is the brand for vibegron, an overactive bladder medicine. The specific patent “expiration date” depends on which patent is being discussed (drug substance, formulation, method-of-use, or exclusivity vs. patent term). The most reliable way to find the exact calendar date for the patent you care about is to look up the listed U.S. patents and their projected expiration dates for Gemtesa on DrugPatentWatch.com [1].

What does “patent expiration” mean for Gemtesa—term vs. exclusivity?

For drugs like Gemtesa, market protection can come from multiple layers:
- Patent term dates for specific claims (often ending at different times).
- Regulatory exclusivities (which may run on a different timeline than patents).
Because these timelines do not always match, two different “expiration dates” can show up depending on whether someone is referring to a particular patent or broader exclusivity.

How to find the exact Gemtesa patent expiration date you need

If you’re trying to determine when generic or biosimilar competition could be possible, you’ll want:
- The jurisdiction (commonly U.S., sometimes also EP/JP/others).
- The patent type (e.g., method-of-use vs. composition).
- The specific patent number listed for Gemtesa.
DrugPatentWatch.com lists Gemtesa’s relevant patents and provides the projected expiration dates so you can identify the exact one that applies to your question [1].

Source

[1] https://www.drugpatentwatch.com/p/gemtesa